{"id":28904,"date":"2026-02-20T22:36:03","date_gmt":"2026-02-20T22:36:03","guid":{"rendered":"https:\/\/su.edu.ye\/chm\/?p=28904"},"modified":"2026-02-20T22:36:03","modified_gmt":"2026-02-20T22:36:03","slug":"masters-degree-awarded-to-mr-sami-ahmed-ali-quait-in-hematology-and-laboratory-blood-transfusion","status":"publish","type":"post","link":"https:\/\/su.edu.ye\/chm\/en\/28904\/","title":{"rendered":"Master’s Degree Awarded to Mr. Sami Ahmed Ali Quait in Hematology and Laboratory Blood Transfusion"},"content":{"rendered":"

Mr. Sami Ahmed Ali Quait <\/strong>was awarded a Master’s degree in the major of Hematology and Laboratory Blood Transfusion <\/strong>with a grade of (Very Good<\/strong>) and an average of (89%<\/strong>) for his thesis titled ” Prevalence of Coagulopathy and Associated Factors among Type II Diabetes Mellitus Patients in Hospitals of Sana’a City -Yemen<\/strong>,” which was submitted to Department of Hematology and Laboratory Blood Transfusion, Faculty of Medicine and Health Sciences – Sana’a University. The defense was held on Tuesday, February 17, 2026.<\/strong><\/h3>\n

The MA Viva-voce Committee, which was formed based on a resolution issued by the Post-Graduate Studies and Scientific Research Council, consisted of the following members:<\/h3>\n\n\n\n\n\n\n
\n

#<\/strong><\/h3>\n<\/td>\n

\n

Committee Members<\/strong><\/h3>\n<\/td>\n

\n

Designation<\/strong><\/h3>\n<\/td>\n

\n

University<\/strong><\/h3>\n<\/td>\n

\n

Position<\/strong><\/h3>\n<\/td>\n<\/tr>\n

\n

1<\/h3>\n<\/td>\n

\n

Prof. Lutfi Abdulsalam Al-Maqtari<\/strong><\/h3>\n<\/td>\n

\n

Internal Examiner<\/h3>\n<\/td>\n

\n

Sana\u2019a Uni.<\/h3>\n<\/td>\n

\n

Chair<\/h3>\n<\/td>\n<\/tr>\n

\n

2<\/h3>\n<\/td>\n

\n

Assoc. Prof. Mohammed Ahmed Hajar<\/strong><\/h3>\n<\/td>\n

\n

Main Supervisor<\/h3>\n<\/td>\n

\n

Sana\u2019a Uni.<\/h3>\n<\/td>\n

\n

Member<\/h3>\n<\/td>\n<\/tr>\n

\n

3<\/h3>\n<\/td>\n

\n

Assoc. Prof. Fouad Ahmed Balkam<\/strong><\/h3>\n<\/td>\n

\n

External Examiner<\/h3>\n<\/td>\n

\n

Hodeidah Uni.<\/h3>\n<\/td>\n

\n

Member<\/h3>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u00a0<\/em><\/strong><\/h3>\n

The study aimed to<\/strong> provide critical insights into the hematological complications of diabetes by:<\/h3>\n
    \n
  • \n

    Assessing the correlation between demographic factors (age, gender, and educational level) and coagulopathy among Type II Diabetes Mellitus patients.<\/h3>\n<\/li>\n
  • \n

    Evaluating the relationship between lifestyle and clinical factors\u2014including regular physical exercise, duration of diabetes, duration of medication, blood pressure, and Body Mass Index (BMI)\u2014with the development of coagulopathy.<\/h3>\n<\/li>\n<\/ul>\n

    \u00a0<\/strong>The study highlighted several significant findings:<\/strong><\/h3>\n
      \n
    • \n

      The prevalence of blood coagulopathy among Type II Diabetes Mellitus patients in Sana\u2019a hospitals is alarmingly high, reaching 54.7%.<\/h3>\n<\/li>\n
    • \n

      The study identified prolonged Prothrombin Time (PT) and prolonged Activated Partial Thromboplastin Time (APTT) as the most frequent coagulation disorders.<\/h3>\n<\/li>\n
    • \n

      Findings underscore the vital importance of coagulation markers as key indicators associated with the overall health status of Type II Diabetes Mellitus<\/h3>\n<\/li>\n<\/ul>\n

      The study<\/strong> concluded with several key recommendations<\/strong>, notably:<\/h3>\n
        \n
      • \n

        Integrate coagulation tests (PT and APTT) and platelet counts into standard evaluation protocols for Type II Diabetes Mellitus patients.<\/h3>\n<\/li>\n
      • \n

        Conduct further research to identify and address the specific clotting factor deficiencies responsible for prolonged PT and APTT.<\/h3>\n<\/li>\n
      • \n

        Implement long-term studies to confirm the predictive value of platelet indices, the Immature Platelet Fraction (IPF), and fibrinogen as biomarkers for cardiovascular events and microvascular complications among Yemeni diabetic patients.<\/h3>\n<\/li>\n<\/ul>\n

        <\/h3>\n

        The study<\/strong> was examined and recommended by the Viva-Voce Committee for acceptance<\/strong> and approval<\/strong>. The defense was attended by a number of academics, researchers, interested individuals, in addition to the candidate\u2019s colleagues and family members.<\/h3>\n

        \"\" \"\" \"\" \"\"<\/p>\n

        To watch the video announcing the verdict and the discussion, click on the link below.<\/h3>\n